Bristol-Myers Squibb

Bristol-Myers SquibbBristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Bristol-Myers Squibb RSS Channel

Display # 
Title Published Date
Bristol-Myers Squibb Foundation awards eight grants totaling nearly $11.5M to make lung and skin cancer screening 01 February 2016
Bristol-Myers Squibb to sell its HIV R&D portfolio to ViiV Healthcare 18 December 2015
Bristol-Myers Squibb and UCLA enter into a collaboration agreement 14 December 2015
Bristol-Myers Squibb Foundation marks World AIDS Day with grants totaling more than $3.5M 01 December 2015
Bristol-Myers Squibb to acquire Cardioxyl Pharmaceuticals, Inc. 02 November 2015
Bristol-Myers Squibb reports third quarter financial results 27 October 2015
Bristol-Myers Squibb's Opdivo (nivolumab) receives expanded FDA approval in previously-treated metastatic non-small cell lung cancer (NSCLC) 12 October 2015
Bristol-Myers Squibb and Moffitt Cancer Center enter into a collaboration agreement 25 September 2015
Bristol-Myers Squibb Employees cycle nearly 2,900 miles to raise money for cancer research 10 September 2015
Bristol-Myers Squibb establishes collaborative Immuno-Oncology Rare Population Malignancy (I-O RPM) program in the U.S. 04 August 2015
Lilly, Bristol-Myers Squibb Restructure Erbitux® (cetuximab) Collaboration in North America 16 April 2015
Bristol-Myers Squibb acquires exclusive license from Novo Nordisk for a discovery research program focused on autoimmune diseases 24 March 2015
FDA approves Opdivo (nivolumab) for the treatment of patients with previously treated metastatic squamous non-small cell lung cancer 05 March 2015
Bristol-Myers Squibb reports fourth quarter and full year 2014 financial results 27 January 2015
Bristol-Myers Squibb and California Institute for Biomedical Research (Calibr) sign worldwide research collaboration 05 January 2015
Bristol-Myers Squibb Foundation awards nine grants to support care for high-risk patients with hepatitis B and C in China and India 03 December 2014
Bristol-Myers Squibb and Five Prime Therapeutics announce exclusive clinical collaboration 25 November 2014
Bristol-Myers Squibb to construct a new large-scale biologics manufacturing facility in Ireland 14 November 2014
Bristol-Myers Squibb enters into agreement that provides an exclusive option to acquire F-star Alpha Ltd. and its novel HER2-targeted therapy 28 October 2014
Bristol-Myers Squibb and Pfizer announce charitable donations of more than $1 million to support cardiovascular education 22 September 2014

Digest World Pharma Newsletter

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]